33
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Autoantibodies and Primary Sjögren's Syndrome in a Hypocitraturic Stone Population

, , , &
Pages 73-80 | Received 30 Nov 1995, Accepted 14 Feb 1996, Published online: 09 Jul 2009

References

  • Backman U, Danielsson B G, Sothell M. A short duration renal acidification test. Scand J Urol Nephrol 1976; 33–48, Suppl. 35
  • Buchalew V M. Nephrolithiasis in renal tubular acidosis. J Urol 1989; 141: 731–737
  • Calmes M, Bartholomew B. SS-A (Ro) antibody in random mother-infant pairs. J Clin Pathol 1985; 38: 73–75
  • Caruana R J, Buchalew V M. The syndrome of distal (Type 1) renal tubular acidosis. Clinical and laboratory findings in 58 cases. Medicine 1988; 67: 84–99
  • Chanarin I, Loewi G, Tavill A S, Swain C P, Tidmarsh E. Defect of renal tubular acidification with antibody to loop of Henle. Lancet 1974; 876: 317–318
  • Conway N S, Maitland A IL, Rennie J B. The urinary citrate excretion in patients with renal calculi. Br J Urol 1949; 21: 30–38
  • Daniels T E, Talal N. Diagnosis and differential diagnosis in Sjögren's syndrome. Sjögren's syndrome: Clinical and immunological aspects, N Talal, H M Moutso-poulos, S S Kassan. Springer Verlag, Berlin 1987; 193–99
  • Dedmon R E, Wrong O. The excretion of organic anion in renal tubular acidosis with particular reference to citrate. Clin Sci 1962; 22: 19–32
  • Eriksson P, Almroth G, Denneberg T, Lindström F. IgG2 deficiency in primary Sjögren's syndrome and hypergammaglobulinemic purpura. Clin Immunol Immunopafhol 1994; 70: 60–65
  • Eriksson P, Denneberg T, Eneström S, Johansson B, Lindström F, Skogh T. Urolithiasis and distal renal tubular acidosis, preceding Primary Sjogren's syndrome. J Int Med 1996, (in press)
  • Eriksson P, Denneberg T, Granerus G, Lindström F. Glomerular filtration rate in Primary Sjögren's Syndrome with renal disease. Scand J Urol Nephrol 1996, (in press)
  • Eriksson P, Denneberg T, Larsson L, Lindström F. Biochemical markers of renal disease in Primary Sjögren's syndrome. Scand J Urol Nephrol 1995; 29: 383–392
  • Fourman P, Robinson J R. Diminished urinary excretion of citrate during deficiencies of potassium in man; preliminary communication. Lancet 1953; 2: 656–657
  • Garder P I, Heier H E. A human autoantibody to renal collecting duct cells associated with thyroid and gastric autoimmunity and possibly renal tubular acidosis. Clin Exp Immunol 1983; 51: 29–37
  • Gobert P, Vanhille Ph, Mougenot B, Lemaire V, Fleury D. Nephrolithiasis revealing Sjögren's syndrome. Kidney Int 1990; 38: 1237–1238
  • Grunbaum B W, Pace N. Determination of citric acid in microliter quantities of urine. Microchemical Journal 1970; 15: 673–676
  • Harley J B. Autoantibodies in Sjögren's syndrome. Sjögren's syndrome, clinical and immunological aspects, N Talal, H M Moutsopoulos, S S Kassan. Springer-Verlag, Heidelberg 1987; 218–234
  • Harrington T M, Bunch T W, van der Berg C J. Renal tubular acidosis. A new look at treatment of musculoskeletal and renal disease. Mayo Clin Proc 1983; 58: 354–360
  • Hess B, Michel R, Takkinen R, Ackermann D, Jaeger Ph. Risk factors for low urinary citrate in calcium nephrolithiasis: low vegetable fibre intake and low urine volume to be added to the list. Nephrol Dial Transplant 1994; 9: 642–649
  • Hodgkinson A. Citric acid excretion in normal adults and in patients with renal calculus. Clin Sci 1962; 23: 203–212
  • Jordan S, Sakai R, Tabak M, Ettenger R, Cohen A, Fine R. Induction of neonatal renal tubular dysfunction by transplacentally acquired IgG from a mother with Sjögren syndrome. J Pediatr 1985; 107: 566–569
  • Konishi K, Hayashi M, Saruta T. Renal tubular acidosis with autoantibody directed to renal collecting-duct cells. N Engl J Med 1994; 331: 1593–1594
  • Lindström F, Eriksson P, Tejle K, Skogh T. IgG subclasses of anti-SS-A/Ro in patients with primary Sjögren's syndrome. Clin Immunol Immunopathol 1994; 73: 358–361
  • Mason A MS, Golding P L. Hyperglobulinemic renal tubular acidosis: A report of nine cases. BMJ 1970; 3: 143–146
  • Pak C YC. Citrate and renal calculi: New insights and future directions. Am J Kidney Dis 1991; 17: 420–425
  • Rudman D, Dedonis J, Fountain M, et al. Hypocitraturia in patients with gastrointestinal malabsorption. N Engl J Med 1980; 303: 657–661
  • Rudman D, Kutner M, Redd S C, Waters W C, Gerron G G, Bleier J. Hypocitraturia in calcium nephrolithiasis. J Clin Endocrinol Metab 1982; 55: 1052–1057
  • Scott W W, Huggins C, Selman B C. Metabolism of citric acid in urolithiasis. J Urol 1943; 50: 202–209
  • Simpson D. Citrate excretion: a window on renal metabolism. Am J Physiol 1983; 244: 223–234
  • Talal N, Zisman E, Shur P H. Renal tubular acidosis, glomerulonephritis and immunologic factors in Sjögren's syndrome. Arthritis Rheum 1968; 11: 774–786
  • Tiselius H G. Urinary excretion in normal subjects and patients with urolithiasis. Urolithiasis. Clinical and basic research, L H Smith, W G Robertson, B Finlayson. Plenum Press, New York-London 1981; 39–44
  • Tompkins D, Toffaletti J. Enzymatic determination of citrate in serum and urine, with use of the Worthington ‘Ultrafree’ device. Clin Chem 1982; 28: 192–195
  • Trudeau D L, Freier E F. Determination of calcium in urine and serum by atomic absorption spectrophotometry (AAS). Clin Chem 1967; 13: 101–114
  • Tu W H, Shearn M A, Lee J C, Hopper J. Interstitial nephritis in Sjogren's syndrome. Ann Intern Med 1968; 6: 1163–1170
  • Vrethem M, Skogh T, Berlin G, Ernerudh J. Autoantibodies versus clinical symptoms in blood donors. J Rheumatol 1992; 19: 1919–1921
  • Winer R L. Sjögren's syndrome. The kidney in collagen vascular diseases, 1st ed, E Grishman, J Churg, M A Needle, V S Venkataseshan. Raven Press, New York 1993; 179–187
  • Wrong O M, Feest T G. The natural history of distal renal tubular acidosis. Contrib Nephrol 1980; 21: 137–144
  • Yamada K, Tamura Y, Tomioka H, Kumagai A. Possible existence of anti-renal tubular plasma membrane autoantibody which blocked parathyroid hormone-induced phosphaturia in a patient with pseudohypoparathyroidism type II and Sjögren's syndrome. Clin Endocrinol Metab 1984; 58: 339–343

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.